NPCE R&D to Revenue
Neuropace Inc · R&D to Revenue
NPCE R&D to Revenue
Latest reported27.89%period ending
NPCE FY R&D/Revenue (49.48% → 27.89%)
Latest values, visible window
High-resolution chart · PNG
NPCE r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 27.8919% | |
| 29.601% | |
| 31.7604% | |
| 48.2118% | |
| 40.305% | |
| 38.1521% | |
| 49.4807% |